Randolph Hecht
Director, UCLA Gastrointestinal Oncology Program · UCLA David Geffen School of Medicine/UCLA Medical Center
Credentials: · · · · ·
History
PresentUCLA Neuroendocrine Tumor Program · UCLA David Geffen School of Medicine/UCLA Medical Center
- 1980–1984
Research
Journal of Clinical Oncology · 2007 · 3,093 citations
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
Nature · 2012 · 1,376 citations
Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2021 · 1,286 citations
18 papers
- LS
14 papers
10 papers
- PH
10 papers
8 papers
- CF
8 papers
- FK
8 papers
- HH
8 papers
Grants
General Clinical Research Center
National Center for Research Resources · M01
Project lead · University of California Los Angeles
Clinical trials
- 2004–2012
Principal investigator · Completed · Phase 3
Hoffmann-La Roche
- 2004–2012
Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors
Principal investigator · Completed · Phase 1
Jonsson Comprehensive Cancer Center
- 2002
Monoclonal Antibody Therapy in Treating Patients With Metastatic Colorectal Cancer
Principal investigator · Completed · Phase 2
Jonsson Comprehensive Cancer Center
- 1998–2005
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Principal investigator · Completed · Phase 2
Jonsson Comprehensive Cancer Center